Global
   
Include All CSL Behring Country Sites

Australia

Pharmaceuticals

Product Name Subcategory Description Business
Tramal Analgesia Used to treat moderate to severe pain. CSL Biotherapies
EpiPen Adrenaline Anaphylaxis Designed for First Aid or Self-Administration in an acute hypersensitivity attack. CSL Biotherapies
EpiPen Jr Adrenaline Anaphylaxis Designed for First Aid or Self-Administration in an acute hypersensitivity attack. CSL Biotherapies
Benpen Antibiotics Used to treat infections caused by susceptible bacteria. CSL Biotherapies
Fucidin Antibiotics Used to treat serious infections caused by susceptible bacteria that have not responded to other antibiotics. CSL Biotherapies
Angiomax Cardiovascular Used to help prevent unwanted blood clotting during an "angioplasty." CSL Biotherapies
THELIN Cardiovascular For the treatment of pulmonary arterial hypertension (high blood pressure in the blood vessels leading to the lungs). CSL Biotherapies
Modavigil Central Nervous System A wakefulness-promoting agent for oral administration. CSL Biotherapies
Advantan Dermatology Indicated for the treatment of eczema and psoriasis. CSL Biotherapies
Daivobet Dermatology Used in the type of psoriasis, where 'plaques' form in the skin. CSL Biotherapies
Daivonex Dermatology Used in mild to moderate chronic plaque type psoriasis. CSL Biotherapies
Finacea Dermatology Topical treatment for papulo-pustular rosacea and mild-to-moderate acne vulgaris. CSL Biotherapies
Solaraze Dermatology Used to manage the skin condition known as actinic or solar keratosis. CSL Biotherapies
Vaniqa Dermatology Used to delay the regrowth of unwanted facial hair in women. CSL Biotherapies
Minijet Adrenaline Emergency Care Used in the management of Cardiac Arrest. CSL Biotherapies
Minijet Atropine Sulfate Emergency Care Used in the management of heart rate abnormalities following Cardiac Arrest. CSL Biotherapies
Minijet Calcium Chloride Emergency Care Used in the management of Cardiac Arrest and treating specific biochemical abnormalities in the blood. CSL Biotherapies
Minijet Glucose Emergency Care Used in the management of low blood sugar level that has led to loss of consciousness. CSL Biotherapies
Minijet Lignocaine Hydrochloride Emergency Care Used to correct severe abnormalities of cardiac rhythm. CSL Biotherapies
Minijet Naloxone Hydrochloride Emergency Care Used in the management of overdose of any opioid medication. CSL Biotherapies
Minijet Sodium Bicarbonate Emergency Care Used to help correct the biochemical abnormality of excess acid in the blood which results from Cardiac Arrest. CSL Biotherapies
Cervidil Obstetrics and Gynecology Used by women who have a normal pregnancy and are near their due date for delivery to prepare for induction. CSL Biotherapies
Burinex Urology Indicated for the treatment of oedema, particularly when associated with congestive heart failure, hepatic and renal diseases. CSL Biotherapies
Flomaxtra Urology Treatment for men who have the condition called benign prostatic hyperplasia (also known as BPH). CSL Biotherapies
Scheriproct Ointment Urology Used in the treatment of haemorrhoids(piles), tears of the anal tissue, and similar conditions. CSL Biotherapies

Australia

Vaccines

Product Name Subcategory Description Business
ADT Booster®   For the prevention of diphtheria and tetanus. CSL Biotherapies
COMVAX®   For the prevention of Haemophilus influenza type b and hepatitis B infection. CSL Biotherapies
Fluvax®   For the prevention of influenza. CSL Biotherapies
Fluvax® Junior   For the prevention of influenza in children aged 6 months to 35 months. CSL Biotherapies
GARDASIL®   For the prevention of cervical, vulvar and vaginal cancer and genital warts caused by Human Papillomavirus types 6,11,16 & 18. CSL Biotherapies
H-B-VAX II®   For the prevention of hepatitis B infection. CSL Biotherapies
Menjugate®   For the prevention of meningococcal group C infection. CSL Biotherapies
MERUVAX II®   For the prevention of rubella. CSL Biotherapies
PedvaxHIB®   For the prevention of Haemophilus influenza type b. CSL Biotherapies
PNEUMOVAX 23®   For the prevention of pneumococcal infections. CSL Biotherapies
Q-VAX®   For the prevention of Q fever. CSL Biotherapies
Rabipur®   For the prevention of rabies. CSL Biotherapies
RotaTeq®   For the prevention of gastroenteritis. CSL Biotherapies
VAQTA®   For the prevention of hepatitis A infection. CSL Biotherapies
VARIVAX Refrigerated®   For the prevention of chickenpox. CSL Biotherapies
Vivotif Oral®   For the prevention of typhoid. CSL Biotherapies
ZOSTAVAX®   For the prevention of shingles. CSL Biotherapies

Australia

Plasma-derived Therapeutics

Product Name Subcategory Description Business
BIOSTATE® Coagulation Disorders Used for patients with haemophilia A, in which there are reduced levels of factor VIII. CSL Bioplasma
MonoFIX®-VF Coagulation Disorders Used in patients with haemophilia B, in which there are reduced levels of Factor IX. CSL Bioplasma
PROTHROMBINEX®-VF Coagulation Disorders Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X. CSL Bioplasma
ALBUMEX®  4 Critical Care Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange. CSL Bioplasma
ALBUMEX® 20 Critical Care Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange. CSL Bioplasma
THROMBOTROL®-VF Critical Care Used for the treatment patients with conditions relating to an inherited deficiency of antithrombin III. CSL Bioplasma
CMV Immunoglobulin-VF Immune Therapy Used to help prevent cytomegalovirus infection in specific transplant patients. CSL Bioplasma
Hepatitis B Immunoglobulin-VF Immune Therapy Used to help prevent hepatitis B infection in a person who comes into contact with suspected infected material. CSL Bioplasma
INTRAGAM® P Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Bioplasma
Normal Immunoglobulin-VF Immune Therapy Used for the replacement of antibodies to help prevent infections. CSL Bioplasma
Rh(D) Immunoglobulin-VF Immune Therapy Used to prevent Haemolytic Disease of the Newborn. CSL Bioplasma
SANDOGLOBULIN® (Lyophilised) Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Bioplasma
SANDOGLOBULIN® NF Liquid Immune Therapy Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders. CSL Bioplasma
Tetanus Immunoglobulin-VF IM Immune Therapy Used to help prevent tetanus in a person who has not recently been immunised against tetanus. CSL Bioplasma
Tetanus Immunoglobulin-VF IV Immune Therapy Used to treat tetanus infection. CSL Bioplasma
Zoster Immunoglobulin-VF Immune Therapy Used to help prevent chickenpox and shingles. CSL Bioplasma

Australia

Antivenoms

Product Name Subcategory Description Business
Black Snake Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Box Jellyfish Antivenom   For the treatment of symptoms of a venomous sting. CSL Biotherapies
Brown Snake Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Death Adder Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Funnel Web Spider Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Polyvalent Snake Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Red Back Spider Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Sea Snake Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Stonefish Antivenom   For the treatment of symptoms of a venomous sting. CSL Biotherapies
Taipan Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies
Tiger Snake Antivenom   For the treatment of symptoms of a venomous bite. CSL Biotherapies

Australia

Diagnostic Products

<
Product Name Subcategory Description Business
Epiclone™ Anti-A ABO Reagent Used to detect the presence of the A antigen on human red cells. Immunohaematology
Epiclone™ Anti-B ABO Reagent Used to detect the presence of the B antigen on human red cells. Immunohaematology
Epiclone™ Anti-A/B ABO Reagent Used to detect the presence of the A and B antigens on human red cells. Immunohaematology
Anti-A1 ABO Reagent Used to detect Group A1 red cells. Immunohaematology
Epiclone™ AHG Poly Anti-Human Globulin Reagent Used for detection of clinically relevant IgG subtypes. Immunohaematology
Abtectcell™ III 0.8% RhD Negative Screening Cells Reagent Red Blood Cells Used in detecting unexpected alloantibodies other than anti-D. Immunohaematology
Celpresol™ LISS Supplementary Reagent Designed for the preservation, suspension and resuscitation of human red blood cells. Immunohaematology
AHG Anti-IgG Anti-Human Globulin Reagent Used for detection of clinically relevant IgG subtypes. Immunohaematology
Epiclone™ Anti-C3d Anti-Human Globulin Reagent Used to only detect the clinically relevant complement components in relation to Anti-C3d. Immunohaematology
Abtectcell™ II 0.8% Pooled Reagent Red Blood Cells Used in detecting unexpected alloantibodies. Immunohaematology
Epiclone™ Anti-C Phenotyping Reagent Used to detect the presence of the C antigen on human red cells. Immunohaematology
Epiclone™ Anti-E Phenotyping Reagent Used to detect the presence of the E antigen on human red cells. Immunohaematology
Epiclone™ Anti-c Phenotyping Reagent Used to detect the presence of the c antigen on human red cells. Immunohaematology
Epiclone™ Anti-e Phenotyping Reagent Used to detect the presence of the e antigen on human red cells. Immunohaematology
Epiclone™ Anti-DCE Phenotyping Reagent Used to detect the presence of the D, C and E antigens on human red cells. Immunohaematology
Epiclone™ Anti-Cw Phenotyping Reagent Used to detect the presence of the Cw antigen on human red cells. Immunohaematology
Epiclone™ Anti-K (Kell) Phenotyping Reagent Used to detect the presence of the K antigen on human red cells. Immunohaematology
Anti-k (Cellano) Phenotyping Reagent Used to detect the presence of the k (Cellano) antigen on human red cells. Immunohaematology
Anti-Kpa Phenotyping Reagent Used to detect the presence of the Kpa antigen on human red cells. Immunohaematology
Anti-Fya Phenotyping Reagent Used to detect the presence of the Fya antigen on human red cells. Immunohaematology
Anti-Fyb Phenotyping Reagent Used to detect the presence of the Fyb antigen on human red cells. Immunohaematology
Epiclone™ Anti-Jka Phenotyping Reagent Used to detect the presence of the Jka antigen on human red cells. Immunohaematology
Epiclone™ Anti-Jkb Phenotyping Reagent Used to detect the presence of the Jkb antigen on human red cells. Immunohaematology
Epiclone™ Anti-M Phenotyping Reagent Used to detect the presence of the M antigen on human red cells. Immunohaematology
Epiclone™ Anti-N Phenotyping Reagent Used to detect the presence of the N antigen on human red cells. Immunohaematology
Epiclone™ Anti-S Phenotyping Reagent Used to detect the presence of the S antigen on human red cells. Immunohaematology
Anti-s Phenotyping Reagent Used to detect the presence of the s antigen on human red cells. Immunohaematology
Epiclone™ Anti-Lea Phenotyping Reagent Used to detect the presence of the Lea antigen on human red cells. Immunohaematology
Epiclone™ Anti-Leb Phenotyping Reagent Used to detect the presence of the Leb antigen on human red cells. Immunohaematology
Abtectcell™ II 0.8% Reagent Red Blood Cells Used to detect unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. Immunohaematology
Abtectcell™ II 3% Reagent Red Blood Cells Used to detect unexpected alloantibodies using tube technique. Immunohaematology
Abtectcell™ III 0.8% Reagent Red Blood Cells Used to detect unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. Immunohaematology
Abtectcell™ III 3% Reagent Red Blood Cells Used to detect unexpected alloantibodies using tube technique. Immunohaematology
Phenocell™ 0.8% Reagent Red Blood Cells Used in identification of unexpected alloantibodies using Column Agglutination Technology (CAT) Systems. Immunohaematology
Phenocell™ 3% Reagent Red Blood Cells Used in identification of unexpected alloantibodies using tube technique. Immunohaematology
Revercell™ 0.8% Reagent Red Blood Cells Used to detect ABO blood group antibodies using Column Agglutination Technology (CAT) Systems. Immunohaematology
Revercell™ 3% Reagent Red Blood Cells Used to detect ABO blood group antibodies using tube techniques. Immunohaematology
Revercell™ 15% Reagent Red Blood Cells Used to detect ABO blood group antibodies using tile techniques. Immunohaematology
A2 Cells 3% Reagent Red Blood Cells Used to detect ABO blood group antibodies and identifying A1 and A2 subgroups. Immunohaematology
AHG Control Cells 3% Reagent Red Blood Cells Used for the confirmation of antiglobulin activity. Immunohaematology
Cord Cells 3% Reagent Red Blood Cells Used for confirming the presence of anti-I in an antibody identification procedure. Immunohaematology
Securacell™ Reagent Red Blood Cells Designed to control, standardise and validate all routine immunohaematology tests.